Apresentações em posters:

1 Terrasso AP, Serra M, Filipe AE, Ferreira AL, Pedroso P, Alves PM, et al. Novel human 3D cell models for neurotoxicity studies. Presented at: International Conference on Stem Cells for Drug Screening and Regenerative Medicine; 2013 Jul 19; Cantanhede, Portugal.

2 Franco Spínola AC, Almeida S, Filipe A, Neves R, Zohreh A, Farre A. Limitations of non-magic bullets compounds in bioequivalence assessment. How can this enhance knowledge towards the development of generic products? The Mycophenolate Mofetil Case. Ehrlich II. Presented at: 2nd World Conference on magic bullets; 2008 Oct 3-5; Nuremberg, Germany.

3 Almeida S, Spínola AC, Alves R, Filipe A, Trabelshi F. Body mass index in the assessment of the bioequivalence of pantoprazole formulations under fed conditions. Presented at: EUFEPS Conference on Bioavailability and Bioequivalence: Focus on Physiological Factors and Variability; 2007 Oct 1-2; Athens, Greece.

4 Almeida S, Portolés A, Terleira A, Filipe A, Cea E, Cruz Caturla M. Truncated AUCs in the assessment of sertraline bioequivalence in healthy volunteers. Presented at: 3rd World Conference on Drug Absorption, Transport and Delivery: clinical significance and regulatory impact. EUFEPS; 2005 Apr 18-20; Barcelona, Spain.

5 Gich I, Antonijoan RM, Puntes M, Mairal E, Almeida S, Barbanoj MJ. Bioequivalencia: los diseños normativos no siempre son suficientes. Presented at: Congreso Nacional de la Sociedad Española de Farmacología Clínica; 2002 Oct 17-19; Pamplona, Spain.